Vacunas La vacunación contra la gripe se relaciona con un 40% menos de riesgo de enfermedad de Alzheimer Home The Issues People who received at least one influenza vaccine were 40% less likely than their non-vaccinated peers to develop Alzheimer’s disease over the course of four years, according to a new study from UTHealth Houston. Research led by first author Avram S. Bukhbinder, MD, a recent alumnus of McGovern Medical School at UTHealth Houston, and senior author Paul. E. Schulz, MD,...

Vacunas La vacuna COVID-19 no afecta negativamente la salud de la placenta, encuentra un estudio Home The Issues Vaccination against COVID-19 had no impact on the health of placentas in pregnant women, according to new research by pathologists at Weill Cornell Medicine and NewYork-Presbyterian. The findings, published June 27 as a research letter in the American Journal of Obstetrics & Gynecology, further emphasize the safety of vaccination during pregnancy for babies and pregnant women, th...

Vacunas La vacuna contra la tuberculosis pasa la prueba de seguridad: estudio Home The Issues No other infectious disease has killed more people than tuberculosis. Currently, only one vaccine is available to prevent severe courses: Bacillus Calmette Guérin (BCG). However, it is not equally effective against all types of tuberculosis. Especially infants and immunocompromised patients are therefore in urgent need for more effective tuberculosis vaccines. A clinical trial in South Africa has now s...

Vacunas Avances prometedores en la búsqueda del diseño de una vacuna pan-coronavirus Home The Issues Researchers at the Francis Crick Institute have shown that a specific area of the SARS-CoV-2 spike protein is a promising target for a pan-coronavirus vaccine that could offer some protection against new virus variants, common colds, and help prepare for future pandemics. Developing a vaccine that provides protection against a number of different coronaviruses is a challenge because this family...